GM

Gigabhai Mandanbhai Rathod

Active Director Director DIN 01046122
DIN 01046122 First appointment May 2000 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2000
Shareholding value •••• Premium profile

About Gigabhai Mandanbhai Rathod

Data last updated:

Gigabhai Mandanbhai Rathod is a Director at Jay Biotech Limited (since 2000). The company operates in Trading. Jay Biotech Limited reported revenue of ₹32.5 Lakh (FY 2025).

DIN 01046122
Primary Designation Director
Industry Trading
First Appointment 19 May 2000
Oldest Company Age 26 yrs
Largest company Jay Biotech Limited · ₹32.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jay Biotech Limited U24231GJ2000PLC038051
Director19 May 20002000₹32.5 Lakh (FY 2025)Active

Board colleagues of Gigabhai Mandanbhai Rathod

Directorship timeline

Open interactive timeline →
Jay Biotech Limited
Premium access

Shareholding and investment profile for Gigabhai Mandanbhai Rathod

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gigabhai Mandanbhai Rathod

Gigabhai Mandanbhai Rathod currently holds 1 directorship: Jay Biotech Limited (Director, since 19 May 2000, revenue ₹32.5 Lakh (FY 2025)).

Gigabhai Mandanbhai Rathod was first appointed on 19 May 2000 as Director at Jay Biotech Limited.

The current boards of Gigabhai Mandanbhai Rathod's companies include Ushaben Gigabhai Rathod (Jay Biotech Limited), Vimalkumar Gigabhai Rathod (Jay Biotech Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available